Evidence for oxidative damage in the autistic brain

Autism: Oxidative Stress, Inflammation, and Immune Abnormalities

Volumn , Issue , 2009, Pages 35-46

  Evans, Teresa A ^a   Perry, George ^a,b   Smith, Mark A ^a   Salomon, Robert G ^a   McGinnis, Woody R ^c   Sajdel Sulkowska, Elizabeth M ^d   Zhu, Xiongwei ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b University of San Antonio   (United States)

^c Autism House   (New Zealand)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85021667980     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (50)

1. Ahlsen, G., Rosengren, L., Belfrage, M., Palm, A., Haglid, K., Hamberger, A., and Gillberg, C. (1993). Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol. Psychiatry 33:734-743.
2. Alvarez, R. A., Aguirre, G. D., Acland, G. M., and Anderson, R. E. (1994). Docosapentaenoic acid is converted to docosahexaenoic acid in the retinas of normal and prcd-affected miniature poodle dogs. Invest. Ophthalmol. Vis. Sci. 35:402-408.
3. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., and Rutter, M. (1995). Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol. Med. 25:63-77.
4. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M., and Lantos, P. (1998). A clinicopathological study of autism. Brain 121(Pt 5):889-905.
5. Chauhan, A. and Chauhan, V. (2006). Oxidative stress in autism. Pathophysiology 13:171-181.
6. Chauhan, A., Chauhan, V., Brown, W. T., and Cohen, I. (2004). Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrinthe antioxidant proteins. Life Sci. 75:2539-2549.
7. Chez, M. G., Buchanan, C. P., Aimonovitch, M. C., Becker, M., Schaefer, K., Black, C., and Komen, J. (2002). Double-blind, placebo-controlled study of l-carnosine supplementation in children with autistic spectrum disorders. J. Child Neurol. 17:833-837.
8. Chung, M. K., Dalton, K. M., Alexander, A. L., and Davidson, R. J. (2004). Less white matter concentration in autism: 2D voxel-based morphometry. Neuroimage 23:242-251.
9. Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., and Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 14:388-394.
10. Connolly, A. M., Chez, M., Streif, E. M., Keeling, R. M., Golumbek, P. T., Kwon, J. M., Riviello, J. J., Robinson, R. G., Neuman, R. J., and Deuel, R. M. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59:354-363.
11. Courchesne, E., Townsend, J., and Saitoh, O. (1994). The brain in infantile autism: Posterior fossa structures are abnormal. Neurology 44:214-223.
12. Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., and Tolbert, L. (1993). A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 17:765-774.
13. Evans, T., Siedlak, S. L., Lu, L., Fu, X., Wang, Z., McGinnis, W. R., Fakhoury, E., Castellani, R. J., Hazen, S. L., Walsh, W. L., Lewis, A. T., Salomon, R. G., Smith, M. A., Perry, G., and Zhu, X. (2008). The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:61-72.
14. Filipek, P. A., Juranek, J., Smith, M., Mays, L. Z., Ramos, E. R., Bocian, M., Masser-Frye, D., Laulhere, T. M., Modahl, C., Spence, M. A., and Gargus, J. J. (2003). Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann. Neurol. 53:801-804.
15. Golse, B., Debray-Ritzen, P., Durosay, P., Puget, K., and Michelson, A. M. (1978). Alterations in two enzymes: Superoxide dismutase and glutathione peroxidase in developmental infantile psychosis (infantile autism). Rev. Neurol. 134:699-705.
16. Grice, D. E. and Buxbaum, J. D. (2006). The genetics of autism spectrum disorders. Neuromol. Med. 8:451-460.
17. Gu, X., Meer, S. G., Miyagi, M., Rayborn, M. E., Hollyfield, J. G., Crabb, J. W., and Salomon, R. G. (2003). Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem. 278:42027-42035.
18. Halliwell, B., Zhao, K., and Whiteman, M. (1999). Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: A personal view of recent controversies. Free Radic. Res. 31:651-669.
19. Horvath, K. and Perman, J. A. (2002). Autism and gastrointestinal symptoms. Curr. Gastroenterol. Rep. 4:251-258.
20. James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., and Neubrander, J. A. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80:1611-1617.
21. James, S. J., Melnyk, S., Jernigan, S., Cleves, M. A., Halsted, C. H., Wong, D. H., Cutler, P., Bock, K., Boris, M., Bradstreet, J. J., Baker, S. M., and Gaylor, D. W. (2006). Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B:947-956.
22. Joosten, E. A. and Houweling, D. A. (2004). Local acute application of BDNF in the lesioned spinal cord anti-inflammatory and anti-oxidant effects. Neuroreport 15:1163-1166.
23. Jyonouchi, H., Sun, S., and Le, H. (2001). Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120:170-179.
24. Keller, F. and Persico, A. M. (2003). The neurobiological context of autism. Mol. Neurobiol. 28:1-22.
25. Kleijnen, J. and Knipschild, P. (1991). Niacin and vitamin B6 in mental functioning: A review of controlled trials in humans. Biol. Psychiatry 29:931-941.
26. Laurence, J. A. and Fatemi, S. H. (2005). Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4:206-210.
27. Lee, H. G., Perry, G., Moreira, P. I., Garrett, M. R., Liu, Q., Zhu, X., Takeda, A., Nunomura, A., and Smith, M. A. (2005). Tau phosphorylation in Alzheimer’s disease: Pathogen or protector? Trends Mol. Med. 11:164-169.
28. McGinnis, W. R. (2004). Oxidative stress in autism. Altern. Ther. Health Med. 10:22-36.
29. Meagher, E. A. and FitzGerald, G. A. (2000). Indices of lipid peroxidation in vivo: Strengths and limitations. Free Radic. Biol. Med. 28:1745-1750.
30. Ming, X., Stein, T. P., Brimacombe, M., Johnson, W. G., Lambert, G. H., and Wagner, G. C. (2005). Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot. Essent. Fatty Acids 73:379-384.
31. Miyagi, M., Sakaguchi, H., Darrow, R. M., Yan, L., West, K. A., Aulak, K. S., Stuehr, D. J., Hollyfield, J. G., Organisciak, D. T., and Crabb, J. W. (2002). Evidence that light modulates protein nitration in rat retina. Mol. Cell Proteomics 1:293-303.
32. Miyazaki, K., Narita, N., Sakuta, R., Miyahara, T., Naruse, H., Okado, N., and Narita, M. (2004). Serum neurotrophin concentrations in autism and mental retardation: A pilot study. Brain Dev. 26:292-295.
33. Money, J., Bobrow, N. A., and Clarke, F. C. (1971). Autism and autoimmune disease: A family study. J. Autism Child Schizophr. 1:146-160.
34. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., and Smith, M. A. (2001). Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:759-767.
35. Nunomura, A., Chiba, S., Lippa, C. F., Cras, P., Kalaria, R. N., Takeda, A., Honda, K., Smith, M. A., and Perry, G. (2004). Neuronal RNA oxidation is a prominent feature of familial Alzheimer’s disease. Neurobiol. Dis. 17:108-113.
36. Poliakov, E., Brennan, M. L., Macpherson, J., Zhang, R., Sha, W., Narine, L., Salomon, R. G., and Hazen, S. L. (2003). Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo. FASEB J. 17:2209-2220.
37. Sajdel-Sulkowska, E. M., Lipinski, B., Windom, H., Audhya, T., and McGinnis, W. (2008). Oxidative stress in autism: Cerebellar 3-nitrotyrosine levels. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:73-84.
38. Sajdel-Sulkowska, E. M., Ming, X., and Koibuchi, N. (2009). Increase in brain neurotrophin-3 and oxidative stress in autism. Cerebellum [Epub PMID 19357934].
39. Schumann, C. M. and Amaral, D. G. (2005). Stereological estimation of the number of neurons in the human amygdaloid complex. J. Comp. Neurol. 491:320-329.
40. Skinner, E. R., Watt, C., Besson, J. A., and Best, P. V. (1993). Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer’s disease and control subjects. Brain 116(Pt 3):717-725.
41. Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., Wiggert, B., Petersen, R. B., and Perry, G. (1994). Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease. Am. J. Pathol. 145:42-47.
42. Sogut, S., Zoroglu, S. S., Ozyurt, H., Yilmaz, H. R., Ozugurlu, F., Sivasli, E., Yetkin, O., Yanik, M., Tutkun, H., Savas, H. A., Tarakcioglu, M., and Akyol, O. (2003). Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin. Chim. Acta 331:111-117.
43. Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., and McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112:420-424.
44. Sweeten, T. L., Posey, D. J., Shankar, S., and McDougle, C. J. (2004). High nitric oxide production in autistic disorder: A possible role for interferon-gamma. Biol. Psychiatry 55:434-437.
45. Takeda, A., Smith, M. A., Avila, J., Nunomura, A., Siedlak, S. L., Zhu, X., Perry, G., and Sayre, L. M. (2000). In Alzheimer’s disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75:1234-1241.
46. Vojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., and Vojdani, E. (2002). Antibodies to neuron-specific antigens in children with autism: Possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 129:168-177.
47. Yao, Y., Walsh, W. J., McGinnis, W. R., and Pratico, D. (2006). Altered vascular phenotype in autism: Correlation with oxidative stress. Arch. Neurol. 63:1161-1164.
48. Yorbik, O., Sayal, A., Akay, C., Akbiyik, D. I., and Sohmen, T. (2002). Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot. Essent. Fatty Acids 67:341-343.
49. Zhu, X., Lee, H. G., Casadesus, G., Avila, J., Drew, K., Perry, G., and Smith, M. A. (2005). Oxidative imbalance in Alzheimer’s disease. Mol. Neurobiol. 31:205-217.
50. Zoroglu, S. S., Armutcu, F., Ozen, S., Gurel, A., Sivasli, E., Yetkin, O., and Meram, I. (2004). Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur. Arch. Psychiatry Clin. Neurosci. 254:143-147.